Delivery Order SPE2DB20D3303-SPE2DB25FZ7A3
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $25,697.77 to AmerisourceBergen Drug Corp for the supply of Myrbetriq ER 50 mg tablets (90-count units) under a firm fixed-price contract. The award was made on August 29, 2025, with an ultimate completion date of September 2, 2025, and represents a non-set-aside competitive award. Performance will take place at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $6,168.18 delivery order to AmerisourceBergen Drug Corp for 90 tablets of Myrbetriq ER 25 mg, a pharmaceutical product for urological treatment. This competitive award, executed on September 23, 2025, with an ultimate completion date of September 24, 2025, represents a firm fixed-price transaction with no set-aside designation. The pharmaceutical will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains...
- The Defense Logistics Agency awarded a delivery order valued at $14,821.01 to AmerisourceBergen Drug Corp for the supply of Myrbetriq ER 50 mg tablets (90-count packages). This competitively awarded, firm fixed-price delivery order was executed on September 4, 2025, with an ultimate completion date of September 5, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 6, 2025, for the supply of Myrbetriq ER 25 mg tablets (90-count package) with a ceiling value of $1,838.82. This firm fixed-price delivery order, with an ultimate completion date of June 9, 2025, represents a non-set-aside, competitively awarded contract. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters and primary...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count) with a ceiling value of $3,977.47. This contract represents a firm fixed-price delivery order under a competitive, non-set-aside procurement and is scheduled for completion by July 25, 2025. The order will be fulfilled from the vendor's Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate office and serves...
- The Defense Logistics Agency awarded a delivery order valued at $2,729.22 to AmerisourceBergen Drug Corp for the supply of Myrbetriq ER 50 mg tablets (30-count supply). This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of August 1, 2025, and represents a competitively awarded transaction under AmerisourceBergen's broader pharmaceutical supply relationships with the federal government. The place of performance is AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $1,262.51 to AmerisourceBergen Drug Corp for Myrbetriq ER 50 mg tablets (90-count supply). This firm fixed-price, non-set-aside delivery order was awarded on June 2, 2025, with an ultimate completion date of June 3, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled the delivery at its corporate office location. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Myrbetriq ER 25 mg tablets (90-count units) with a ceiling value of $46,869.28. This firm fixed-price delivery order, with an ultimate completion date of September 29, 2025, represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the...
- The Defense Logistics Agency awarded a delivery order valued at $6,884.16 to AmerisourceBergen Drug Corp for 90-tablet bottles of Myrbetriq ER 50 mg tablets. The contract is a firm fixed-price delivery order with an ultimate completion date of September 26, 2025, and represents a competitive award with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $6,868.68 for 90 tablets of Myrbetriq ER 25 mg on July 14, 2025, with ultimate completion by July 15, 2025. This non-set-aside contract employs firm fixed pricing and represents a delivery order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The product will be performed at the contractor's Conshohocken, Pennsylvania location, the company's...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB25FZ7A3Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $6,036.26 to AmerisourceBergen Drug Corp for the supply of Myrbetriq ER 25 mg tablets (90-count units) under a firm fixed price contract. The award was made on May 1, 2025, with an ultimate completion date of May 2, 2025, and carries no set-aside designation. Performance will take place at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen's contract portfolio demonstrates consistent competitively awarded delivery orders across multiple therapeutic domains, supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.0k | 5/1/25 |